Top compounds associated with response to OR2L13


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.03
mRNA TG-100-115 CTRPv2 pan-cancer AAC -0.075 0.04
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.068 0.04
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.04
mRNA QL-XI-92 GDSC1000 pan-cancer AAC 0.061 0.04
mRNA Vinorelbine GDSC1000 pan-cancer AAC -0.07 0.04
mRNA BX-795 GDSC1000 pan-cancer AAC -0.069 0.04
mRNA NG-25 GDSC1000 pan-cancer AAC 0.059 0.04
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.04
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.04
Download CSV